Updated Outcomes from the Historical Control Study SCHOLAR-3 Contextualizing ZUMA-3 Results of Brexucabtagene Autoleucel (KTE-X19) in Adult Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL)

Autor: Shah, Bijal, Ghobadi, Armin, Oluwole, Olalekan, Logan, Aaron, Boissel, Nicolas, Cassaday, Ryan, Leguay, Thibaut, Bishop, Michael, Topp, Max, Tzachanis, Dimitrios, O'Dwyer, Kristen, Arellano, Martha, Lin, Yi, Baer, Maria, Schiller, Gary, Park, Jae, Subklewe, Marion, Abedi, Mehrdad, Minnema, Monique, Wierda, William, Deangelo, Daniel, Stiff, Patrick, Jeyakumar, Deepa, Dong, Jinghui, Adhikary, Sabina, Zhou, Lang, Schuberth, Petra, Faghmous, Imi, Masouleh, Behzad Kharabi, Houot, Roch

Publikováno v: 64th ASH Annual Meeting and Exposition
64th ASH Annual Meeting and Exposition, Dec 2022, New Orleans, United States. pp.3158-3161, ⟨10.1182/blood-2022-158248⟩

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd363fd029ca7015f12ed0a029af10c2
https://doi.org/10.1182/blood-2022-158248

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

521 - Zuma-25: A Phase 2 Study of Brexucabtagene Autoleucel (KTE-X19) Chimeric Antigen Receptor T-Cell Therapy in Adult Patients with Relapsed/Refractory Rare B-Cell Malignancies

Autor: Eichhorst, Barbara, Dunleavy, Kieron, Tiacci, Enrico, Buske, Christian, Jain, Nitin, Castillo, Jorge J., Rossi, Davide, Woolven, Kate, Masouleh, Behzad Kharabi, Peng, Weimin, Schuberth, Petra C., Domper, Neus, Wolthers, Benjamin O., Palomba, M. Lia

Publikováno v: In Transplantation and Cellular Therapy February 2023 29(2) Supplement:S390-S391

Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1)

Autor: Petrausch Ulf, Schuberth Petra C, Hagedorn Christian, Soltermann Alex, Tomaszek Sandra, Stahel Rolf, Weder Walter, Renner Christoph

Publikováno v: BMC Cancer, Vol 12, Iss 1, p 615 (2012)

Abstract Background Asbestos is the main cause of MPM in industrialized countries. Even since asbestos is banned in most developed countries, the peak wave of MPM incidence is anticipated for the next years due to the long latency of asbestos induced

Externí odkaz: https://doaj.org/article/14d372475b6a4f2ea62255aa72483301